Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05554094 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 31, 2025 to Jul 31, 2026v7
  2. Primary completion date: Aug 31, 2025 to Dec 31, 2025v6
  3. Primary completion date: Jan 31, 2025 to Aug 31, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jul 31, 2025 to Dec 31, 2025
    • Site details revised
    v5
  4. Eligibility criteria shortened, about 13 wordsv4
  5. Primary completion date: Jan 31, 2024 to Jan 31, 2025
    • Study completion date: Jan 31, 2025 to Jul 31, 2025
    v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ohio State University
253 trials monitored
See 12 trials at risk
PTSD
889 trials monitored
See 54 trials at risk
The primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.
Trial Details
NCT Number NCT05554094
Lead Sponsor Ohio State University
Conditions
(from sponsor)		 PTSD, Stress Disorders, Traumatic, Stress Disorders, Post-Traumatic, Trauma and Stressor Related Disorders, Mental Disorder
Related terms Mental Disorders, Stress Disorders, Post-Traumatic, Stress Disorders, Traumatic, Trauma and Stressor Related Disorders
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov